It’s easy to blame COVID. But Australia has suffered medicine shortages for years. The pandemic has only highlighted the problem. Here’s what we could do to better avoid shortages in the first place.
Academic rigor, journalistic flair
Articles on Medical supply chains
Displaying all articles
We’re on the road again. Getting enough COVID-19 vaccine to where it’s needed in a given time frame is the next logistical hurdle.
Drug shortages occur regularly in the US, even in the best of times. The pharmaceutical supply chain embodies ‘just in time’ shipping and has little built-in redundancy.
Every year, thousands of medical devices and drugs are recalled in the US. But the decision to recall a flawed product is often left up to the manufacturer.
It’s not a matter of if, but when, the next deadly pandemic will strike. Will the world be ready?
Top contributors
-
Associate Dean For Global One Health, College of Veterinary Medicine & Biomedical Sciences; and Director, Pandemic and Biosecurity Policy Program, Scowcroft Institute for International Affairs, Bush School of Government and Public Service, Texas A&M University
-
Assistant Professor, Texas A&M University
-
Director of the Scowcroft Institute of International Affairs and Executive Professor, Texas A&M University
-
Associate Professor - Innovation & Entrepreneurship, EDHEC Business School
-
Associate Professor of Operations and Decision Technologies, Kelley School of Business, Indiana University
-
Professor, RMIT University
-
Professor of Industrial and Operations Engineering, University of Michigan
-
Ph.D. Candidate in Industrial and Operations Engineering, Clemson University
-
Professor, Head of Department, Information Systems and Business Analytics, RMIT University
-
Lecturer, Supply Chain Management, RMIT University
-
Associate Professor of Supply Chain Management, University of Agder
-
Lecturer and Researcher, Supply Chains and Operations, Victoria University
